Net Income

Micro-cap BSEG racks up awards against giants like Variety, but with a volatile stock and weak fundamentals, can creative success spark a financial turnaround?

Canada adds four groups to its terror list, taking a bold stand against online networks preying on youth and global insurgencies. Here's what it means.

Vision Fortune Finance Institute unveils a powerful new data engine for its Nexus AI, aiming to revolutionize financial research by taming data overload.

Enverus unveils an 'AI operating system' for energy, promising a 10x productivity boost. But what does this mean for the industry's security and future?

A regulatory filing reveals a key investor's move as Alkermes' $2.1B bid for Avadel and its blockbuster narcolepsy drug, LUMRYZ, nears its final act.

A $2.4B deal for AI's future. A hedge fund's strategic play. We decode the battle for Alphawave, the company powering the next tech revolution.

A Texas utility automated 90% of its collection calls with AI. The real story isn't just efficiency, but how it creates a fairer, more humane process.

The 2025 proxy season saw record director support as investors prioritized financials, yet dissent over executive pay signals a new battleground.

A struggling interactive entertainment firm bets its future on gold, targeting Malaysia's booming market. A look at the high-stakes pivot shaking up BHAT.

With a new patent, this biotech targets the massive orthopedics market. But can its novel fibroblast therapy overcome steep financial and clinical hurdles?

How a super-regional insurer's full-scale cloud modernization with Guidewire is a strategic move to boost agility and precision in challenging markets.

USA Rare Earth is accelerating its timeline to mine critical minerals by two years. Can innovative tech and bold strategy break foreign supply chain dominance?

BlockQuarry unveils a sleek new website for its US-made miner, but can this digital pivot overcome steep financial hurdles and disrupt a crowded market?

Beyond philanthropy, KinderCare's alumni scholarship is a strategic investment in its brand, building a human capital pipeline from the ground up.

Quantum Computing Inc. is leaving the lab for Las Vegas, betting its US-made photonic chips can solve real-world AI problems and justify a lofty valuation.

Ontario's new FAST program speeds access to cancer drugs like Scemblix, challenging Canada's slow reimbursement system. Is this a new national blueprint?

The space firm secures vital cash through a complex warrant deal, but at what cost to shareholders? All eyes are now on a critical investor vote.

Promising data for NuCana's NUC-7738 offers hope for tough-to-treat melanoma, but the biotech's financial health presents a critical hurdle.

With new clinical data and recent FDA approval, IceCure Medical's tumor-freezing tech is paving a new, less-invasive path for breast cancer treatment.

Glean's new research institute and context-aware agents offer a pragmatic path for businesses struggling to operationalize AI safely and effectively.